OBJECTIVE: To review the literature on mannose-binding lectin (MBL) polymorphisms and susceptibility for upper respiratory tract infection (URI) in children and adolescents. DATA SOURCES: We searched PubMed from 1966 and EMBASE from 1974 to July 2005, using the terms respiratory tract infection, respiratory infection, upper respiratory infection, MBL, and mannose-binding lectin. STUDY SELECTION: Initially, 110 studies were identified. Two reviewers independently screened identified titles and abstracts. Potentially relevant studies were obtained and the full text examined. Inclusion criteria were human subjects, 18 years or younger, URI, and MBL polymorphisms. Seven of the initially identified studies met the inclusion criteria. DATA EXTRACTION: Information was gathered for each study on study design, population, possible confounders, and outcomes measured. DATA SYNTHESIS: Because there was significant heterogeneity between the identified studies, we had to describe the identified studies separately. The largest case-control studies (n = 3) as well as the cohort study (n = 1) suggest an association between MBL polymorphisms and URI, especially in young children. Results of the smaller studies (n = 3) are inconsistent. CONCLUSIONS: The association between MBL polymorphisms and URI in children remains controversial. Large prospective cohort studies with regular documentation of URI and possible confounders such as atopy and environmental factors are required to establish the role of MBL polymorphisms in susceptibility for URI.
OBJECTIVE: To review the literature on mannose-binding lectin (MBL) polymorphisms and susceptibility for upper respiratory tract infection (URI) in children and adolescents. DATA SOURCES: We searched PubMed from 1966 and EMBASE from 1974 to July 2005, using the terms respiratory tract infection, respiratory infection, upper respiratory infection, MBL, and mannose-binding lectin. STUDY SELECTION: Initially, 110 studies were identified. Two reviewers independently screened identified titles and abstracts. Potentially relevant studies were obtained and the full text examined. Inclusion criteria were human subjects, 18 years or younger, URI, and MBL polymorphisms. Seven of the initially identified studies met the inclusion criteria. DATA EXTRACTION: Information was gathered for each study on study design, population, possible confounders, and outcomes measured. DATA SYNTHESIS: Because there was significant heterogeneity between the identified studies, we had to describe the identified studies separately. The largest case-control studies (n = 3) as well as the cohort study (n = 1) suggest an association between MBL polymorphisms and URI, especially in young children. Results of the smaller studies (n = 3) are inconsistent. CONCLUSIONS: The association between MBL polymorphisms and URI in children remains controversial. Large prospective cohort studies with regular documentation of URI and possible confounders such as atopy and environmental factors are required to establish the role of MBL polymorphisms in susceptibility for URI.
Authors: Ferenc Fekete; Balázs Fadgyas; Éva Papp; Ágnes Szilágyi; Zoltán Prohászka; Brigitta Müller; Gábor Kovács Journal: Pathol Oncol Res Date: 2015-10-03 Impact factor: 3.201
Authors: Susan E Olivo-Marston; Ping Yang; Leah E Mechanic; Elise D Bowman; Sharon R Pine; Christopher A Loffredo; Anthony J Alberg; Neil Caporaso; Peter G Shields; Stephen Chanock; Yanhong Wu; Ruoxiang Jiang; Julie Cunningham; Jin Jen; Curtis C Harris Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.254
Authors: Christopher Miller; Sara Wilgenbusch; Mini Michaels; David S Chi; George Youngberg; Guha Krishnaswamy Journal: Clin Mol Allergy Date: 2010-03-25
Authors: Lena Hafrén; Erna Kentala; Elisabet Einarsdottir; Juha Kere; Petri S Mattila Journal: Curr Allergy Asthma Rep Date: 2012-12 Impact factor: 4.806
Authors: J M Ruskamp; M O Hoekstra; D S Postma; M Kerkhof; R W Bottema; G H Koppelman; M M Rovers; A H Wijga; J C de Jongste; B Brunekreef; E A M Sanders Journal: Clin Exp Immunol Date: 2009-03 Impact factor: 4.330
Authors: Jopje M Ruskamp; Maarten O Hoekstra; Dirkje S Postma; Marjan Kerkhof; Renske W Bottema; Gerard H Koppelman; Maroeska M Rovers; Alet H Wijga; Johan C de Jongste; Bert Brunekreef; Elisabeth A Sanders Journal: J Infect Dis Date: 2008-12-01 Impact factor: 5.226
Authors: Luregn Jan Schlapbach; Philipp Latzin; Nicolas Regamey; Claudia E Kuehni; Marcel Zwahlen; Carmen Casaulta; Christoph Aebi; Urs Frey Journal: Pediatr Allergy Immunol Date: 2008-08-12 Impact factor: 6.377
Authors: Inna G Ovsyannikova; Iana H Haralambieva; Stephen N Crooke; Gregory A Poland; Richard B Kennedy Journal: Immunol Rev Date: 2020-07-13 Impact factor: 12.988